A Look at Recent Transactions Shaping the Future of Healthcare
This week's article provides a summary of recent healthcare M&A news for October 2, 2024.
The healthcare industry is rapidly evolving, with the lines between the healthcare technology and services sectors blurring - creating the catalyst for innovation, transformation, and continued market activity. TripleTree's Healthcare M&A Weekly summarizes recent mergers, acquisitions, and investments shaping the future of healthcare.
To view previous healthcare M&A activity, please review last week's post: Healthcare M&A Weekly - September 24, 2024.
-
H.I.G Capital announced the sale of its portfolio company, BIOVECTRA, a contract development and manufacturing organization (CDMO) of pharmaceutical ingredients, to Agilent Technologies (NYSE: A), a global provider of laboratory instruments, software, and services for a purchase price of $925M. Read more about the acquisition here.
-
Blue Wolf Capital Partners, announced that it has finalized the acquisition of seven European pharmaceutical manufacturing facilities from Recipharm, a contract development and manufacturing organization. Read more about the acquisition here.
-
Bradford Health Services, a provider of addiction treatment and recovery services backed by Lee Equity Partners, announced the acquisition of Lakeview Health, a behavioral health provider known for its specialized programs across the country. View the announcement here.
-
DSN Software, a provider of software solutions for specialty dental practices, announced a strategic growth investment from Vertica Capital Partners, a New-York based software investment firm. Click here for more on the strategic growth investment.
-
eMolecules Inc., a provider of a chemical compound search-and fulfillment platform for early discovery chemistry research, announced that it has acquired Synple Chem AG, a company that specializes in automated chemical synthesis systems. Learn more about the acquisition here.
-
Everise, a global healthcare customer experience provider, announced that it has signed a binding agreement to acquire the healthcare vertical of Continuum Global Solutions (CGS), a customer services management company, from SkyView Capital. This strategic move enhances Everise’s capabilities in pharmacy benefit management. Read more about the acquisition here.
-
GC Therapeutics, an operator of a genome-wide cell landscape exploration company intended to program patient-derived stem cells, raised $65M in Series A funding to scale their cell therapy offerings. Read more about the funding here.
-
Helaina, a biotechnology company that creates human equivalent bioactive proteins, announced it has raised $45M in Series B Funding which was led by Avidity Partners. View the press release here.
-
Mendaera, a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced the closing of $73M in Series B funding led by Threshold Ventures. Click here for more on the funding.
-
Molecular Designs, a provider of PCR assays, announced the acquisition of Lamba Biotech, a provider of research products for application in molecular biology and gene therapy. Learn more about the acquisition here.
-
MontecitoPLUS, an innovator in physician-focused solutions, announced its acquisitions of Arrowlytics, a provider of practice analytics services. Read more about the acquistiion here.
-
OncoC4, a biopharmaceutical company developing medicines for cancer, and AcroImmune, a biopharmaceutical company developing immunotherapy drugs, announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction. Learn more about the merger.
-
Pace Life Sciences, a contract development, and manufacturing organization (CDMO) and a Division of Pace, a science and technology company backed by Aurora Capital Partners and Leonard Green & Partners, announced that it has acquired Catalent's Center-of-Excellence for Small Molecule Analytical Services. Read more about the acquisition here.
-
Pafford Medical Services, a provider of emergency medical transport and healthcare services, announced its acquisition of Wadley Regional Medical Center, renaming the facility as Southwest Arkansas Regional Medical Center to ensure stability of the facility. Learn more here.
-
PharmaCord, a provider of patient services and commercialization solutions to life science companies, announced that the funds advised by Permira, have successfully completed their investment in the company. Click here for more on the investment.
-
Longuevue Capital announced that its portfolio company, Pinnacle Clinical Research, a clinical trial site organization specializing in therapeutic areas, has acquired Jubilee Clinical Research, a multi-therapeutic site based in Las Vegas, Nevada. Read more about the acquisition here.
-
Pomelo Care, a value-based virtual provider of maternity care, announced the acquisition of the The Doula Network, a network of credentialed, in-network doulas in the U.S. This acquisition follows Pomelo’s recent $46M Series B funding raise. View the press release here.
-
Sanner Group, a global healthcare packaging and medical device CDMO has acquired Gilero LLC, a medical device design, development, and contract manufacturer based out of North Carolina. Learn more about the acquisition here.
-
Telix, an Australian-based imaging agent developer, has reached a deal to acquire RLS (USA) Inc., an operator of America’s only Joint Commission-accredited radiopharmacy network, for up to $250M. Click here to learn more.
-
VALD, a global health technology company that is the system of choice for musculoskeletal (MSK) health professionals, announced a growth equity investment from FTV Capital. Read more about the growth equity investment here.
-
Vitalograph, a manufacturer of medical equipment and supply of respiratory diagnostic devices, announced the acquisition of Massachusetts-based Morgan Scientific, a PFT software vendor and long-term partner of the respiratory diagnostic leader. Read more about the acquisition here.
-
Zing Health, a Medicare Advantage insurer, announced that it has raised $140M in a funding round that was led by venture investors: Health 2047 Capital Partners, CRG, and First Trust Capital. Learn more about the funding round here.
Transactions outlined in this summary highlight some of the key trends shaping the future of healthcare. Get the latest industry news from TripleTree every week.
This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. All product names, logos and brands are property of their respective owners. All company, product and service names used in this communication are for identification purposes only. Use of these names, logos and brands does not imply endorsement.
